Epstein-Barr virus (EBV) is a highly prevalent human herpesvirus associated with infectious mononucleosis and several malignant diseases. Our portfolio of recombinant EBV antigens supports reliable serological assay development and diagnostic applications.
We offer recombinant antigens derived from key EBV targets, including viral capsid antigens (VCA), early antigens (EA), and nuclear antigens (EBNA). Produced under controlled conditions, these antigens provide high purity, excellent consistency, and dependable performance across ELISA and other immunoassay platforms.
